Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,110 hedge funds and large institutions have $109B invested in Allergan plc in 2015 Q4 according to their latest regulatory filings, with 166 funds opening new positions, 394 increasing their positions, 445 reducing their positions, and 99 closing their positions.
68% more first-time investments, than exits
New positions opened: 166 | Existing positions closed: 99
15% more funds holding in top 10
Funds holding in top 10: 157 → 181 (+24)
14% more capital invested
Capital invested by funds: $96.1B → $109B (+$13.1B)
5% more funds holding
Funds holding: 1,056 → 1,110 (+54)
11% less call options, than puts
Call options by funds: $5.28B | Put options by funds: $5.91B
11% less repeat investments, than reductions
Existing positions increased: 394 | Existing positions reduced: 445
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$1.28B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.01B |
| 3 |
TP
Third Point
New York
|
+$515M |
| 4 |
EM
Elliott Management
New York
|
+$404M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$389M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
-$1.03B |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$709M |
| 3 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$540M |
| 4 |
PC
Paulson & Co
New York
|
-$491M |
| 5 |
Jennison Associates
New York
|
-$419M |
AGN Hedge Fund Activity: Q4 2015 in Review
1,110 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2015, worth a combined $109B — up 14% from $96.1B a quarter earlier.
Buyers outnumbered sellers: 166 funds opened new AGN positions and 99 closed out — a net gain of 67 holders — while 394 added to existing stakes and 445 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $1.28B. The largest seller was Sculptor Capital, cutting an estimated $1.03B.
- 1,110 institutional investors held Allergan plc (AGN) as of Q4 2015, up from 1,056 in Q3 2015.
- Funds reported $109B of Allergan plc stock for Q4 2015, up 14% quarter-over-quarter.
- 166 funds opened new Allergan plc positions in Q4 2015 and 99 closed out, a net change of +67 holders.
- The largest Allergan plc buyer in Q4 2015 was Pentwater Capital Management, an estimated $1.28B added.
- The largest Allergan plc seller in Q4 2015 was Sculptor Capital, an estimated $1.03B sold.
Based on aggregated 13F filings for Q4 2015.